2013-08-19 07:03:01 -
Oslo, Norway, 19 August 2013 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will announce its first
half and second quarter 2013 results on Wednesday, 28 August 2013. A
presentation by members of Algeta's executive management team to investors,
analysts and the press will take place in Oslo at 10:00 CET.
The presentation will also be webcast live and can be accessed through
www.algeta.com where questions can also be submitted during the presentation.
The presentation will take place at 10:00 CET at:
Haakon VIIs gate 9
will also host an international conference call at 14:30 CET/08:30
Eastern Time (US) (details below).
To participate in the conference call, please dial the appropriate number below
five minutes prior to the call:
US: +1 877 423 0830
UK: +44 20 7153 9154
Norway: +47 21 06 61 13
Sweden: +46 8-506 443 86
Denmark: +45 32 71 42 62
Switzerland: +41 44 580 65 22
Participant pin code: 197187#
To access the replay, please dial:
US: +1 877 679 2989
UK: +44 203 364 5200
Norway: +47 23 50 02 03
Sweden: +46 8-505 564 73
Conference reference: 348084#
A replay of the conference call will also be available at www.algeta.com.
The results report and the presentation will be available at www.algeta.com in
the Investors section from 07:00 CET.
For further information, please contact:
Mike Booth / Renate Birkeli +47 23 00 67 32
Communications & Corporate Affairs firstname.lastname@example.org
Mark Swallow +44 207 638 9571
Citigate Dewe Rogerson email@example.com
Knut Ekern +47 22 04 82 00
Gambit Hill & Knowlton firstname.lastname@example.org
Kari Watson +1 781 235 3060
MacDougall Biomedical Communications email@example.com
Tricia Swanson +1 646 378 2953
The Trout Group firstname.lastname@example.org
Algeta is a company focused on developing novel targeted therapies for patients
with cancer based on its alpha-pharmaceutical platform. The Company is
headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in
Cambridge, MA performing commercial marketing operations in the US. Algeta is
listed on the Oslo Stock Exchange (Ticker: ALGETA). For more information please
This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Algeta ASA via Thomson Reuters ONE